Sboner, Andrea

Publications

Sort by

Co-Author Network

selected publications

Whole genome sequencing elucidates etiological differences in MCPyV-negative Merkel cell carcinoma. Pathology, research and practice. 2024 Academic Article GET IT
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution. Nature. 2024 Academic Article GET IT
Detection of rare and novel gene fusions in patients with diffuse glioma: An institutional retrospective study. Journal of neuropathology and experimental neurology. 2024 Academic Article GET IT
Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival. 2024 GET IT
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology. European urology focus. 2024 Academic Article GET IT
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nature communications. 2024 Academic Article GET IT
Canonical AREs are tumor suppressive regulatory elements in the prostate. 2024 GET IT
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2024 Academic Article GET IT
NIPBL::NACC1 Fusion Hepatic Carcinoma. The American journal of surgical pathology. 2023 Academic Article GET IT
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases. 2023 GET IT
Evolution of structural rearrangements in prostate cancer intracranial metastases. NPJ precision oncology. 2023 Academic Article GET IT
Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. Journal of the National Cancer Institute. 2023 Academic Article GET IT
The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Cold Spring Harbor molecular case studies. 2023 Academic Article GET IT
The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Academic Article GET IT
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 Academic Article GET IT
Times cited: 26
Whole-genome characterization of myoepithelial carcinomas of the soft tissue. Cold Spring Harbor molecular case studies. 2022 Academic Article GET IT
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer. Cancer research. 2022 Academic Article GET IT
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood advances. 2022 Academic Article GET IT
African Ancestry Associated Gene Expression Profiles in Triple Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent. Cancer discovery. 2022 Academic Article GET IT
GLI1-Rearranged Enteric Tumor: Expanding the Spectrum of Gastrointestinal Neoplasms with GLI1 gene fusions. The American journal of surgical pathology. 2022 Academic Article GET IT
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR). Molecular carcinogenesis. 2022 Academic Article GET IT
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science (New York, N.Y.). 2022 Academic Article GET IT
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer. The Journal of experimental medicine. 2022 Academic Article GET IT
Times cited: 9
Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors. Neuro-oncology advances. 2022 Academic Article GET IT
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Molecular oncology. 2022 Academic Article GET IT
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies. The Journal of pathology. 2022 Academic Article GET IT
Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology. The Journal of molecular diagnostics : JMD. 2022 Review GET IT
Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130. Oncogene. 2022 Academic Article GET IT
Application of Artificial Intelligence to Overcome Clinical Information Overload in Urologic Cancer. BJU international. 2021 Review GET IT
Are we there yet? A machine learning architecture to predict organotropic metastases. BMC medical genomics. 2021 Academic Article GET IT
G3BP1 inhibits Cul3^SPOP to amplify AR signaling and promote prostate cancer. Nature communications. 2021 Academic Article GET IT
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. Nature communications. 2021 Academic Article GET IT
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity. Cell reports. 2021 Academic Article GET IT
Times cited: 1
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2021 Academic Article GET IT
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors. NPJ genomic medicine. 2021 Academic Article GET IT
MicroRNA-1205 Regulation of FRYL in Prostate Cancer. Frontiers in cell and developmental biology. 2021 Academic Article GET IT
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. The oncologist. 2021 Academic Article GET IT
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage. Communications biology. 2021 Academic Article GET IT
Times cited: 5
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nature communications. 2021 Academic Article GET IT
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia. NPJ precision oncology. 2021 Academic Article GET IT
Times cited: 21
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. The Journal of clinical investigation. 2021 Academic Article GET IT
A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion. Journal of magnetic resonance imaging : JMRI. 2021 Academic Article GET IT
Times cited: 51
Patient-derived xenografts and organoids model therapy response in prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 89
Common germline-somatic variant interactions in advanced urothelial cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 22
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome. Archives of pathology & laboratory medicine. 2020 Academic Article GET IT
Times cited: 1
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology. Translational oncology. 2020 Academic Article GET IT
Times cited: 9
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes. European urology open science. 2020 Academic Article GET IT
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity. Nature communications. 2020 Academic Article GET IT
Times cited: 76
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples. Thyroid : official journal of the American Thyroid Association. 2020 Academic Article GET IT
Times cited: 23
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. Cell. 2020 Academic Article GET IT
Times cited: 126
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 2020 Academic Article GET IT
Times cited: 30
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma. Acta neuropathologica communications. 2020 Academic Article GET IT
Times cited: 17
Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations. Cancers. 2020 Academic Article GET IT
Times cited: 21
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA. Bioinformatics (Oxford, England). 2020 Academic Article GET IT
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes. Nature communications. 2020 Academic Article GET IT
Times cited: 39
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 118
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular cancer therapeutics. 2020 Academic Article GET IT
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 32
Clinical features of neuroendocrine prostate cancer. European journal of cancer. 2019 Academic Article GET IT
Times cited: 204
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 57
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 26
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. The Journal of clinical investigation. 2019 Academic Article GET IT
Times cited: 114
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019 Academic Article GET IT
Times cited: 157
Genomic correlates of clinical outcome in advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019 Academic Article GET IT
Times cited: 804
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis. Cancer cell. 2019 Academic Article GET IT
Times cited: 60
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer. Science translational medicine. 2019 Academic Article GET IT
Times cited: 124
The application of precision medicine in diagnosing familial Mediterranean fever. Leukemia & lymphoma. 2019 Letter GET IT
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018 Academic Article GET IT
Times cited: 7
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Molecular cell. 2018 Academic Article GET IT
Times cited: 61
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 182
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma. The Journal of pathology. 2018 Academic Article GET IT
Times cited: 18
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer. JCO precision oncology. 2018 Academic Article GET IT
Times cited: 33
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018 Academic Article GET IT
Times cited: 466
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy. JCO precision oncology. 2018 Academic Article GET IT
Patient derived organoids to model rare prostate cancer phenotypes. Nature communications. 2018 Academic Article GET IT
Times cited: 255
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 64
The long tail of oncogenic drivers in prostate cancer. Nature genetics. 2018 Academic Article GET IT
Times cited: 567
Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer. Cell reports. 2018 Academic Article GET IT
Times cited: 31
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2017 Academic Article GET IT
Times cited: 41
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. The Journal of clinical investigation. 2017 Academic Article GET IT
Times cited: 27
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer cell. 2017 Academic Article GET IT
Times cited: 56
Molecular alterations in prostate cancer and association with MRI features. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 13
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. Genome biology. 2017 Academic Article GET IT
Times cited: 24
Inherited determinants of early recurrent somatic mutations in prostate cancer. Nature communications. 2017 Academic Article GET IT
Times cited: 26
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models. JCO precision oncology. 2017 Academic Article GET IT
Times cited: 43
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations. Journal of the American Medical Informatics Association : JAMIA. 2017 Academic Article GET IT
Times cited: 81
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer discovery. 2017 Academic Article GET IT
Times cited: 722
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer cell. 2017 Academic Article GET IT
Times cited: 149
Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nature genetics. 2016 Academic Article GET IT
Times cited: 229
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. Cancer cell. 2016 Academic Article GET IT
Times cited: 392
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care. NPJ genomic medicine. 2016 Academic Article GET IT
Times cited: 66
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein. Oncotarget. 2016 Academic Article GET IT
Times cited: 17
PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma. Thrombosis research. 2016 Academic Article GET IT
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer. JAMA oncology. 2016 Academic Article GET IT
Times cited: 44
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nature medicine. 2016 Academic Article GET IT
Times cited: 1150
The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Academic Article GET IT
Times cited: 2257
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer. Nature. 2015 Academic Article GET IT
Times cited: 186
SPOP mutation leads to genomic instability in prostate cancer. eLife. 2015 Academic Article GET IT
Times cited: 144
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA oncology. 2015 Academic Article GET IT
Times cited: 229
Integrative clinical genomics of advanced prostate cancer. Cell. 2015 Academic Article GET IT
Times cited: 2492
ASEQ: fast allele-specific studies from next-generation sequencing data. BMC medical genomics. 2015 Academic Article GET IT
Times cited: 45
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature communications. 2014 Academic Article GET IT
Times cited: 528
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nature genetics. 2014 Academic Article GET IT
Times cited: 451
Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014 Academic Article GET IT
Times cited: 1144
Unraveling the clonal hierarchy of somatic genomic aberrations. Genome biology. 2014 Academic Article GET IT
Times cited: 80
MTSS1 is a metastasis driver in a subset of human melanomas. Nature communications. 2014 Academic Article GET IT
Times cited: 42
SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (New York, N.Y.). 2014 Academic Article GET IT
Times cited: 122
Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 148
Assessment of transcript reconstruction methods for RNA-seq. Nature methods. 2013 Academic Article GET IT
Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 39
Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 289
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456. The Journal of pathology. 2013 Article GET IT
Times cited: 1
Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 138
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 438
Punctuated evolution of prostate cancer genomes. Cell. 2013 Academic Article GET IT
Times cited: 1004
Epigenomic alterations in localized and advanced prostate cancer. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Identifying an ERG-positive subclass with clinical progression using expression profiling. European urology. 2013 Editorial Article GET IT
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 193
An integrated encyclopedia of DNA elements in the human genome. Nature. 2012 Academic Article GET IT
Times cited: 12641
VAT: a computational framework to functionally annotate variants in personal genomes within a cloud-computing environment. Bioinformatics (Oxford, England). 2012 Academic Article GET IT
Times cited: 54
Genomic analysis of the hydrocarbon-producing, cellulolytic, endophytic fungus Ascocoryne sarcoides. PLoS genetics. 2012 Academic Article GET IT
Times cited: 68
IQSeq: integrated isoform quantification analysis based on next-generation sequencing. PloS one. 2012 Academic Article GET IT
Times cited: 5
Genomics and privacy: implications of the new reality of closed data for the field. PLoS computational biology. 2011 Information Resource GET IT
Times cited: 63
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer discovery. 2011 Academic Article GET IT
Times cited: 735
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Science translational medicine. 2011 Academic Article GET IT
Times cited: 210
The real cost of sequencing: higher than you think!. Genome biology. 2011 Academic Article GET IT
Times cited: 285
A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS biology. 2011 Academic Article GET IT
Times cited: 902
Diverse protein kinase interactions identified by protein microarrays reveal novel connections between cellular processes. Genes & development. 2011 Academic Article GET IT
Times cited: 60
The genomic complexity of primary human prostate cancer. Nature. 2011 Academic Article GET IT
Times cited: 1026
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science (New York, N.Y.). 2010 Academic Article GET IT
Times cited: 767
RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries. Bioinformatics (Oxford, England). 2010 Academic Article GET IT
Times cited: 81
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome research. 2010 Academic Article GET IT
Times cited: 164
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome biology. 2010 Academic Article GET IT
Times cited: 135
Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays. BMC genomics. 2010 Academic Article GET IT
Times cited: 89
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC medical genomics. 2010 Academic Article GET IT
Times cited: 193
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. Nucleic acids research. 2010 Academic Article GET IT
Times cited: 19
Robust-linear-model normalization to reduce technical variability in functional protein microarrays. Journal of proteome research. 2009 Academic Article GET IT
Times cited: 44
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia (New York, N.Y.). 2009 Academic Article GET IT
Times cited: 107
Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes, chromosomes & cancer. 2009 Academic Article GET IT
Times cited: 86
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International journal of cancer. 2008 Academic Article GET IT
Times cited: 32
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Journal of the National Cancer Institute. 2008 Academic Article GET IT
Times cited: 272
The role of disorder in interaction networks: a structural analysis. Molecular systems biology. 2008 Academic Article GET IT
Times cited: 191
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer research. 2007 Academic Article GET IT
Times cited: 60
UbcH10 is overexpressed in malignant breast carcinomas. European journal of cancer. 2007 Academic Article GET IT
Times cited: 63
Comparing classical pathways and modern networks: towards the development of an edge ontology. Trends in biochemical sciences. 2007 Academic Article GET IT
Times cited: 46
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene. 2006 Academic Article GET IT
Times cited: 64
TMABoost: an integrated system for comprehensive management of tissue microarray data. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society. 2006 Academic Article GET IT
Times cited: 21
An automated procedure to properly handle digital images in large scale tissue microarray experiments. Computer methods and programs in biomedicine. 2005 Academic Article GET IT
Times cited: 16
Modeling clinical judgment and implicit guideline compliance in the diagnosis of melanomas using machine learning. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2005 Academic Article GET IT
Times cited: 17
Clinical validation of an automated system for supporting the early diagnosis of melanoma. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2004 Academic Article GET IT
Times cited: 18
[Tissue microarrays in oncology]. Pathologica. 2003 Academic Article GET IT
Times cited: 2
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. Medical informatics and the Internet in medicine. 2003 Academic Article GET IT
Times cited: 17
A multiple classifier system for early melanoma diagnosis. Artificial intelligence in medicine. 2003 Academic Article GET IT
Times cited: 92
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. Journal of telemedicine and telecare. 2002 Academic Article GET IT
Times cited: 7
Design and initial implementation of a regional tele-oncology project. Journal of telemedicine and telecare. 2000 Academic Article GET IT
Times cited: 9

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer awarded by National Cancer Institute Co-Investigator 2024 - 2029
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response awarded by National Cancer Institute Co-Investigator 2021 - 2026
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers awarded by National Cancer Institute Co-Investigator 2021 - 2026
Personalized in vitro models to advance precision health equity awarded by National Cancer Institute Co-Investigator 2024 - 2025
Clonal Hematopoiesis as a determinant for bone marrow toxicities for targeted radiation therapies in prostate cancer. awarded by United States Department of Defense Co-Investigator 2022 - 2025
Research collaboration agreement w/ Eli Lilly and Company awarded by Eli Lilly and Company Co-Investigator 2019 - 2025
Collaborative genomic alterations and transcriptional control in prostate cancer awarded by National Cancer Institute Co-Investigator 2019 - 2025
Unraveling the landscape of homologous recombination deficiency in patients with breast and prostate cancer across the African diaspora in NYC awarded by National Institute of General Medical Sciences Co-Investigator 2020 - 2024
missing activity Co-Investigator 2018 - 2023

more ...

less ...

Background

education and training

Ph.D., University of Trento (Italy) 2005
M.S., University of Trento (Italy) 1998

Contact

full name

Andrea Sboner

primary email

ans2077@med.cornell.edu

VIVO Weill Cornell Medical College

Andrea Sboner Associate Professor

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email